Drug Safety: FDA's Future Inspection Plans Need to Address Issues Presented by COVID-19 Backlog V. GAO-21-409T

About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

table,div,span,font,p{display:none}Please click here if you are not redirected within a few seconds.

GAO-21-409T 1 (2021-03-04)

handle is hein.gao/gaobaecoa0001 and id is 1 raw text is:

GA1O

For Release on Delivery
Expected at 10:00 am. EST
Thursday, March 4, 2021

United States Government Accountability Office
Testimony before the Subcommittee on
Agriculture, Rural Development, Food
and Drug Administration, and Related
Agencies, Committee on Appropriations,
House of Representatives

DRUG SAFETY

FDA's Future Inspection
Plans Need to Address
Issues Presented by
COVID-19 Backlog

Statement of Mary Denigan-Macauley, Director,
Health Care

GAO 100
A Century of Non-Partisan Fact-Based Work

GAO-21-409T